Top-News

Idorsia Aktie News

Aktie
WKN:  A2DTEB ISIN:  CH0363463438 US-Symbol:  IDRSF Branche:  Biotechnologie Land:  Schweiz
4,11 €
+0,02 €
+0,49%
08:44:19 Uhr
Depot/Watchlist
Marktkapitalisierung *
618,49 Mio. €
Streubesitz
55,25%
KGV
-0,58
Dividende
11,03 €
Dividendenrendite
268,74%
Index-Zuordnung
-

Idorsia News

27.02.25 - GlobeNewswire
Invitation to Idorsia's Full Year 2024 Financial Reporting webcast and conference call
Idorsia will publish its Full Year 2024 Financial Reporting on Tuesday March 4, 2025, at 07:00 CET.
26.02.25 - GlobeNewswire
Idorsia reaches an agreement with significant bondholders to restructure its convertible bond debt and to secure funding for future operations
Ad hoc announcement pursuant to Art. 53 LR
26.02.25 - GlobeNewswire
Idorsia and Viatris update their collaboration for selatogrel and cenerimod
Ad hoc announcement pursuant to Art. 53 LR
26.02.25 - GlobeNewswire
Idorsia is released from exclusivity constraint regarding the global rights to aprocitentan – now pivoting to alternative parties
Ad hoc announcement pursuant to Art. 53 LR
25.02.25 - GlobeNewswire
Bondholders approve amended terms of the 2025 convertible bonds
Ad hoc announcement pursuant to Art. 53 LR
12.02.25 - GlobeNewswire
Idorsia publishes the resolutions for the upcoming bondholder meeting
Ad hoc announcement pursuant to Art. 53 LR
26.01.25 - Börse-Global
Idorsia Aktie: Warum jetzt Zweifel aufkommen
Die Schweizer Biotech-​Firma Idorsia verzeichnet weiterhin eine schwierige Phase an der Börse. Der aktuelle Aktienkurs liegt bei 0,77 Euro, was einem signifikanten Monatsverlust ...
15.01.25 - GlobeNewswire
Idorsia presents at J.P. Morgan Healthcare Conference 2025 – fighting to create value for all stakeholders
Ad hoc announcement pursuant to Art. 53 LR
14.01.25 - GlobeNewswire
Idorsia publishes an invitation to a bondholder meeting
Ad hoc announcement pursuant to Art. 53 LR
13.01.25 - GlobeNewswire
Idorsia to call for a bondholder meeting
Ad hoc announcement pursuant to Art. 53 LR
20.12.24 - GlobeNewswire
Idorsia provides update on the exclusive negotiations for the global rights to aprocitentan
Ad hoc announcement pursuant to Art. 53 LR

Newssuche

Videos

newspaper
08.12.25 0,00%
Technical Trading: Die besten 3 Tage
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Abschluss!
Grande Portage Resources Ltd
0,234 €
+18,8%
Grande Portage Resources Ltd Chart
Sprott zieht durch - und der Markt sollte aufwachen!
Mehr zur Aktie »